A detailed history of High Tower Advisors, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, High Tower Advisors, LLC holds 21,041 shares of AMRN stock, worth $10,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,041
Previous 121,391 82.67%
Holding current value
$10,941
Previous $83,000 84.34%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.57 - $0.8 $57,199 - $80,280
-100,350 Reduced 82.67%
21,041 $13,000
Q2 2024

Aug 13, 2024

BUY
$0.63 - $1.07 $11,781 - $20,009
18,700 Added 18.21%
121,391 $83,000
Q1 2024

May 06, 2024

BUY
$0.82 - $1.35 $3,269 - $5,382
3,987 Added 4.04%
102,691 $91,000
Q4 2023

Feb 12, 2024

BUY
$0.66 - $0.91 $9,684 - $13,353
14,674 Added 17.46%
98,704 $85,000
Q3 2023

Nov 08, 2023

BUY
$0.85 - $1.43 $8,456 - $14,227
9,949 Added 13.43%
84,030 $77,000
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.49 $12,797 - $17,024
11,426 Added 18.24%
74,081 $88,000
Q1 2023

May 11, 2023

BUY
$1.19 - $2.19 $4,165 - $7,665
3,500 Added 5.92%
62,655 $93,000
Q4 2022

Feb 08, 2023

SELL
$1.07 - $1.34 $19,398 - $24,292
-18,129 Reduced 23.46%
59,155 $71,000
Q3 2022

Nov 09, 2022

BUY
$1.09 - $1.67 $4,971 - $7,616
4,561 Added 6.27%
77,284 $81,000
Q2 2022

Aug 10, 2022

SELL
$1.13 - $3.69 $839 - $2,741
-743 Reduced 1.01%
72,723 $108,000
Q1 2022

May 12, 2022

BUY
$2.85 - $3.73 $48,569 - $63,566
17,042 Added 30.2%
73,466 $239,000
Q4 2021

Feb 10, 2022

SELL
$3.24 - $5.18 $294 - $471
-91 Reduced 0.16%
56,424 $189,000
Q3 2021

Nov 12, 2021

BUY
$3.94 - $5.84 $13,100 - $19,418
3,325 Added 6.25%
56,515 $288,000
Q2 2021

Aug 06, 2021

BUY
$4.26 - $6.5 $37,637 - $57,427
8,835 Added 19.92%
53,190 $234,000
Q1 2021

May 10, 2021

BUY
$5.03 - $8.8 $33,927 - $59,356
6,745 Added 17.93%
44,355 $274,000
Q4 2020

Feb 10, 2021

SELL
$4.04 - $5.31 $6,686 - $8,788
-1,655 Reduced 4.21%
37,610 $184,000
Q3 2020

Nov 13, 2020

BUY
$3.64 - $7.76 $5,460 - $11,640
1,500 Added 3.97%
39,265 $166,000
Q2 2020

Aug 10, 2020

SELL
$4.78 - $8.26 $43,737 - $75,579
-9,150 Reduced 19.5%
37,765 $262,000
Q1 2020

May 21, 2020

BUY
$4.0 - $21.53 $187,660 - $1.01 Million
46,915 New
46,915 $186,000
Q4 2019

Feb 14, 2020

SELL
$13.94 - $24.12 $913,014 - $1.58 Million
-65,496 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$13.89 - $23.16 $203,210 - $338,830
14,630 Added 28.76%
65,496 $995,000
Q2 2019

Aug 13, 2019

BUY
$16.27 - $20.51 $157,981 - $199,152
9,710 Added 23.59%
50,866 $986,000
Q1 2019

May 15, 2019

BUY
$12.61 - $22.33 $126,629 - $224,237
10,042 Added 32.27%
41,156 $852,000
Q4 2018

Feb 14, 2019

BUY
$12.41 - $22.98 $16,865 - $31,229
1,359 Added 4.57%
31,114 $423,000
Q3 2018

Nov 09, 2018

BUY
$2.45 - $16.27 $72,899 - $484,113
29,755 New
29,755 $486,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $210M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.